These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26838220)

  • 1. Reliability and Validity of an Iranian Version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Multiple Myeloma: the EORTC QLQ-MY20.
    Ahmadzadeh A; Yekaninejad MS; Saffari M; Pakpour AH; Aaronson NK
    Asian Pac J Cancer Prev; 2016; 17(1):255-9. PubMed ID: 26838220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in multiple myeloma: clinical validation of the Mexican-Spanish version of the QLQ-MY20 instrument.
    Espinoza-Zamora JR; Portilla-Espinosa CM; Labardini-Méndez JR; Cervera E; Niesvisky R; Oñate-Ocaña LF
    Ann Hematol; 2015 Jun; 94(6):1017-24. PubMed ID: 25563595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability and validity of the Greek QLQ-C30 and QLQ-MY20 for measuring quality of life in patients with multiple myeloma.
    Kontodimopoulos N; Samartzis A; Papadopoulos AA; Niakas D
    ScientificWorldJournal; 2012; 2012():842867. PubMed ID: 22919356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.
    Cocks K; Cohen D; Wisløff F; Sezer O; Lee S; Hippe E; Gimsing P; Turesson I; Hajek R; Smith A; Graham L; Phillips A; Stead M; Velikova G; Brown J;
    Eur J Cancer; 2007 Jul; 43(11):1670-8. PubMed ID: 17574838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Quality of Life Multiple Myeloma Module Questionnaire (QLQ-MY20) in Portuguese myeloma patients.
    Graça Pereira M; Ferreira G; Pereira M; Faria S; Bacalhau R; Monteiro S; Fernandes B; Vilaça M
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13128. PubMed ID: 31273859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.
    Proskorovsky I; Lewis P; Williams CD; Jordan K; Kyriakou C; Ishak J; Davies FE
    Health Qual Life Outcomes; 2014 Mar; 12():35. PubMed ID: 24618388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and reliability of the QLQ-MY20 module for assessing the health-related quality of life in Brazilians with multiple myeloma.
    Malta JS; Silveira LP; Drummond PLM; Costa NL; Dos Santos RMM; Reis IA; Reis AMM; de Pádua CAM
    Curr Med Res Opin; 2021 Jul; 37(7):1163-1169. PubMed ID: 33979261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
    Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
    Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17.
    Yekaninejad MS; Pakpour AH; Tadakamadla J; Kumar S; Mosavi SH; Fridlund B; Bottomley A; Aaronson NK
    Support Care Cancer; 2015 May; 23(5):1215-24. PubMed ID: 25312650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
    Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
    Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran.
    Khoshnevisan A; Yekaninejad MS; Ardakani SK; Pakpour AH; Mardani A; Aaronson NK
    Health Qual Life Outcomes; 2012 May; 10():54. PubMed ID: 22607028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life in patients with gastric cancer: translation and psychometric evaluation of the Iranian version of EORTC QLQ-STO22.
    Sadighi S; Montazeri A; Sedighi Z; Mohagheghi MA; Froutan H
    BMC Cancer; 2009 Aug; 9():305. PubMed ID: 19715606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.
    Ripping TM; Rammant E; Witjes JA; Aaronson NK; van Hemelrijck M; van Hoogstraten LMC; ; Kiemeney LA; Aben KKH
    Health Qual Life Outcomes; 2022 Dec; 20(1):171. PubMed ID: 36581934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: the EORTC QLQ-BM22.
    Yekaninejad MS; Ahmadzadeh A; Mosavi SH; Saffari M; Pakpour AH; Tolooei F; Chow E; Bottomley A
    Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):147-56. PubMed ID: 24328844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module.
    Paradowska D; Bereza K; Sanna B; Kucharska E; Tomaszewska IM; Dudkiewicz Z; Skotnicki P; Bottomley A; Tomaszewski KA
    Eur J Oncol Nurs; 2017 Aug; 29():148-154. PubMed ID: 28578847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Azeri Version of European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30): Translation and Validation.
    Davudov MM; Harirchi I; Amiraliyev N; Mehtiyeva E; Mirzajani Z; Amiraliyev K; Rustamli N; Zebardast J; Montazeri A
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):267-271. PubMed ID: 31983195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstruction.
    Winters ZE; Afzal M; Rutherford C; Holzner B; Rumpold G; da Costa Vieira RA; Hartup S; Flitcroft K; Bjelic-Radisic V; Oberguggenberger A; Panouilleres M; Mani M; Catanuto G; Douek M; Kokan J; Sinai P; King MT;
    Br J Surg; 2018 Feb; 105(3):209-222. PubMed ID: 29116657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
    Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
    BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric evaluation of Azeri version of the head and neck cancer specific quality of life questionnaire (EORTC QLQ-H&N43).
    Davudov MM; Rahimov C; Harirchi I; Mirzajani Z; Amiraliyev N; Amiraliyev K; Rustamova N; Zebardast J; Montazeri A
    Health Qual Life Outcomes; 2020 Jul; 18(1):248. PubMed ID: 32703297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.